Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2005

View Archived Issues

Stat3 identified as a novel target for contraception

(R)-Etodolac is cytotoxic to multiple myeloma cells in vitro and ex vivo

Mycophenolate mofetil reduces activity of refractory systemic lupus erythematosus

MT-103 deemed safe and effective in studies with chimpanzees

NN-1731 offers a better hemostatic potential than recombinant FVIIa

Novel agents for treating eating disorders claimed by sanofi-aventis

Novel therapeutics for cardiovascular diseases reported

Companies disclose new treatments for diabetes

Antiretroviral efficacy of stampidine is evident in FIV-infected cats

Defibrotide and oligotide prevent chemotherapy-induced damage of endothelial cells

Bezafibrate and medroxyprogesterone enter phase II studies for AML treatment

Biovitrum and Santhera sign license agreement for DPP-IV program

Phase II study of oxypurinol fails to meet endpoints

Dosing completed in first part of phase I study of ACV-1

Epimmune and IDM join to become IDM Pharma

AMDL's DR-70 test shows utility in detecting ovarian cancer

Target selected in Celera Genomics and Seattle Genetics' collaboration

Targeting microglia relieves spinal cord injury pain

In vivo effects of TRPV1 antagonism for pain associated with gastroesophageal reflux

Antiinflammatory effects of a novel EP4 agonist

X-Cell Medical begins study of estradiol-eluting stent

Crucell and U.S. Navy sign CRADA for AdVac vaccines for anthrax and plague

Large Scale Biology and BioCatalytics enter collaboration agreement

Odyssey Thera and NIH to advance Molecular Libraries Roadmap Initiative

Chiron obtains PER.C6 research license

Safety, tolerability and antiviral efficacy of GW-695634 in NNRTI-resistant HIV-1-infected patients

Singulair approved for symptoms of perennial allergic rhinitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...